Skip to main content

AMERIPRISE FINANCIAL INC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 820027 MINNEAPOLIS, MN

Position in SUPN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,989,148
-$7,893 QoQ
Shares Held
173,905
-3.9% QoQ
Ownership
0.300%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 55.86900894166356.ToString("F0")% None 44.13099105833645.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $745,649,307 across 34 Drug Manufacturers - Specialty & Generic names. SUPN ranks #10 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SUPN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,989,148 173,905
2025-12-31 $8,997,041 181,027
2025-09-30 $8,760,623 183,315
2025-06-30 $5,458,475 173,175
2025-03-31 $14,825,400 452,684
2024-12-31 $16,281,437 450,261
2024-09-30 $17,025,994 546,055
2024-06-30 $15,097,994 564,411
2024-03-31 $19,315,469 566,270
2023-12-31 $16,197,775 559,702
2023-09-30 $15,687,853 569,019
2023-06-30 $17,892,462 595,225
2023-03-31 $24,594,336 678,839
2022-12-31 $24,908,003 698,290
2022-09-30 $26,861,904 793,557
2022-06-30 $23,860,734 825,060
2022-03-31 $27,385,220 847,315
2021-12-31 $24,066,563 825,328
2021-09-30 $22,389,944 839,518
2021-06-30 $24,731,789 803,241
2021-03-31 $20,027,097 764,977
2020-12-31 $18,997,158 755,054
2020-09-30 $14,394,979 690,738
2020-06-30 $15,158,318 638,245
2020-03-31 $14,091,422 783,292